14th Annual Focus on Pharmacology Conference

D6999

+ Add to Google Calendar + Add to Outlook

The purpose of this activity is to provide pharmacology information in multiple areas and to promote clinical excellence by improving the quality of care to patients.

The primary audience is nurse practitioners, physician assistants, and advanced practice clinicians; however, the program content is relevant to physicians and the broader health care community.

This activity includes one hour of opioid continuing education.

• 7:15 a.m. | Check-In/Continental Breakfast/Visit Exhibitors
• 7:45 a.m. | Welcome
  Carol Forsyth, MSN, CRNP, FNP-BC, Committee Chair
• 7:50 a.m. | Plenary Session
  Opioids: An Update on the Epidemic and Overview of Prescribing and Weaning Strategies (Opioid Credit)
  David Giampetro, MD

  Objectives

  • Discuss the changes in the opioid epidemic over the last 10 to 15 years and why the Centers for Disease Control and Prevention guidelines needed to be revised.
  • Describe how to taper opioid therapy, recognize the risks of tapering opioids and list five signs/symptoms of opioid withdrawal.
  • Define buprenorphine and explain why it is probably the best choice of presently available opioids for chronic pain.
• 8:50 a.m. | Move to Concurrent Session
• 8:55 a.m. | Concurrent Session 1
  

  1A Pediatric Track

  Pediatric Hyperlipidemia Management for the Non-Lipidologist: Expanding the Toolset
  Thomas Dispenza, MD

  Objectives

  • Formulate an appropriate nutraceutical regimen for pediatric hyperlipidemia patients.
  • Appraise and improve medication lists for managing excessive weight gain refractory to lifestyle interventions.

  1B Acute Care Track

  Cognitive Disorders in the Acute Care Setting
  Barbara Birriel, PhD, ACNP-BC, FCCM

  Objectives

  • Differentiate dementia, delirium and other cognitive disorders.
  • Develop a prevention and treatment plan for patients experiencing cognitive disorders in the acute care setting.

  1C Primary Care Track

  Tightening the Cuff on Blood Pressure Management
  Julie Jones, PA-C

  Objectives

  • Define hypertension and how to be confident in the timing of medical treatment based on 2017 AHA/ACC guidelines.
  • Describe how to make an educated choice in choosing medical management of hypertension based on individual situations.
  • Identify four pharmacological options for hypertension treatment.
• 9:55 a.m. | Break/Visit Exhibitors/Posters
• 10:10 a.m. | Plenary Session
  CANNabinoid Drug Interaction Review (CANN-DIR)
  Paul Kocis, PharmD, RPh, MPH

  Objectives

  • Describe the pharmacokinetic principles of Absorption, Distribution, Metabolism and Excretion (ADME).
  • Describe drug-drug interactions from the perspective of how a cannabinoid may affect the metabolism of another concomitantly prescribed medication(s).
  • Describe how CANN-DIR can be utilized as part of the medication reconciliation process.
  • Demonstrate how CANN-DIR’s drug-drug interaction results can be printed in multiple languages and provided to another health care provider, patient and/or caregiver.
• 11:10 a.m. | Lunch/Visit Exhibitors/Posters
• 12:10 p.m. | Plenary Session
  Medical Marijuana: Practical Implications and Considerations
  Steven Riela, MD

  Objectives

  • Discuss the process of certification for medical marijuana.
  • Explore some of the common medication interactions with medical marijuana.
• 1:10 p.m. | Move to Concurrent Session
• 1:15 p.m. | Concurrent Session 2
  

  2A Pediatric Track

  Treatment of Epilepsy in Children
  Gayatra Mainali, MD

  Objectives

  • Explain how to choose the first anti-seizure medication (ASM) in patients with newly diagnosed epilepsy.
  • Interpret when to refer refractory epilepsy patients for further management, such as ketogenic diet, epilepsy surgery and vagus nerve stimulator.

  2B Acute Care Track

  Corticosteroids in Acute Care: What, Why, and When
  Jacqueline Thoryk, MSN, CRNP, AG-ACNP

  Objectives

  • Identify commonly used steroid preparations in the inpatient care areas.
  • Characterize various indications, doses and side effects of commonly used steroid preparations in the inpatient care areas.

  2C Primary Care Track

  Pharmacotherapy for Obesity
  Victoria Grille, MD

  Objectives

  • Review the new bariatric weight loss medications (*GLP-1 agonists).
  • Explain bariatric weight loss medication’s mechanism of action and side effects.
  • Discuss the management of bariatric weight loss medications in the perioperative setting.
• 2:15 p.m. | Break/Visit Exhibitors/Posters
• 2:30 p.m. | Concurrent Session 3
  

  3A Pediatric Track

  Managing Common Pediatric Gastrointestinal (GI) Conditions in the Primary Care Setting
  Lisa KH Ingalls, MSN, CRNP, PPCNP-BC
  Lindsay DeMoss, MSN, CRNP, FNP-BC

  Objectives

  • Discuss treatment and management strategies for constipation and diarrhea in pediatric patients.
  • Describe treatment strategies used for functional abdominal pain in pediatric patients.

  3B Acute Care Track

  Sepsis: Diagnosis and Management
  Elizabeth Sodomin, MD

  Objectives

  • Define sepsis.
  • Establish how to diagnose sepsis.
  • Identify indicators of decline and progression of sepsis.
  • Establish algorithms for the management of sepsis and its complications.

  3C Primary Care Track

  Pharmacotherapy for Smoking Cessation
  Janet Cady, DNP, RN, FNP-C, CGRN

  Objectives

  • Discuss the benefits, risks and appropriate use of non-prescription/over-the-counter medication interventions for smoking cessation in both the inpatient and outpatient settings.
  • Discuss the benefits, risks and appropriate use of prescription medications for smoking cessation in both the inpatient and outpatient settings.
• 3:30 p.m. | Move to General Session
• 3:35 p.m. | Closing Plenary Session
  Triiodothyronine (T3) or No T3: The Conundrum of the Use of Liodothyronine in the Persistently Symptomatic Patient With Normal Thyroid-Stimulating Hormone (TSH) on Levothyroxine
  Andrea Manni, MD

  Objectives

  • Describe the approach to the hypothyroid patient who is symptomatic despite normal TSH on thyroxine replacement.
  • Discuss the pros and cons of liodothyronine T3 treatment under the above circumstances.
• 4:35 p.m. | Adjournment

Carol Forsyth, MSN, CRNP, FNP-BC
Committee Chair
Family Nurse Practitioner
Penn State Bone and Joint Institute

Directed and Supported by the Advanced Practice Advisory Board

Betsy Avinash, MSN, CRNP, FNP-C
Family Nurse Practitioner
Department of Urology
Penn State Health Milton S. Hershey Medical Center

David Brinton, MSN, CRNP, FNP-BC, AGACNP-BC
Manager Advanced Practice Providers
Department of Surgery
Penn State Health Milton S. Hershey Medical Center

Suzanne Frazier, MS, CRNP, CHFN, NP-C
Heart Failure Nurse Practitioner, Heart Failure Disease Management Program
Penn State Heart and Vascular Institute

Rachel Fultz, MSPAS, PA-C
Physician Assistant
Department of Otolaryngology-Head and Neck Surgery
Penn State Health Milton S. Hershey Medical Center

David Giampetro, MD
Associate Professor of Anesthesiology and Perioperative Medicine and Neurology
Director of Inpatient and Outpatient Opioid Stewardship
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Jaime Halin, MHS, PA-C
Physician Assistant
Penn State Bone and Joint Institute

Robin Kingston, MSN, CRNP, CPNP
Pediatric Nurse Practitioner
Pediatric Home Ventilator Program
Penn State Health Children’s Hospital

Marnie ODonnell, MS, PA-C
Children’s Heart Group, Physician Assistant
Pediatric Electrophysiology
Penn State Health Children’s Hospital

Bonnie Wilson, MS, CRNP, AGACNP-BC, ANP-C
Acute Care Nurse Practitioner
Penn State Health Milton S. Hershey Medical Center

Barbara Birriel, PhD, ACNP-BC, FCCM
Assistant Research Professor, Nursing and Bioethics
Ross and Carol Nese College of Nursing
Penn State

Janet Cady, DNP, RN, FNP-C, CGRN
Lung Cancer Screening Program Manager, Interventional Pulmonology
Division of Pulmonary, Allergy and Critical Care Medicine
Penn State Health Milton S. Hershey Medical Center

Lindsay DeMoss, MSN, CRNP, FNP-BC
Nurse Practitioner
Department of Pediatrics
Penn State Health Milton S. Hershey Medical Center

Thomas Dispenza, MD
Assistant Professor of Pediatrics
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

David Giampetro, MD
Associate Professor of Anesthesiology and Perioperative Medicine and Neurology
Director of Inpatient and Outpatient Opioid Stewardship
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Victoria Grille, MD
Fellow, Department of Surgery
Division of Minimally Invasive Surgery/Bariatrics
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Lisa KH Ingalls, MSN, CRNP, PPCNP-BC
Nurse Practitioner
Department of Pediatrics
Penn State Health Milton S. Hershey Medical Center

Julie Jones, PA-C
Children’s Heart Group, Physician Assistant
Penn State Health Children’s Hospital

Paul Kocis, PharmD, RPh, MPH
Assistant Professor of Pharmacology
Clinical Pharmacist
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Gayatra Mainali, MD
Associate Professor of Pediatrics
Division of Neurology
Associate Professor of Neurology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Andrea Manni, MD
Professor of Medicine
Chief, Division of Endocrinology, Diabetes and Metabolism
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Steven Riela, MD
Assistant Professor of Anesthesiology and Perioperative Medicine
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Elizabeth Sodomin, MD
Department of Surgery
Division of Minimally Invasive Surgery/Bariatrics
Penn State Health Milton S. Hershey Medical Center

Jacqueline Thoryk, MSN, CRNP, AG-ACNP
Advanced Practice Clinician
Department of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Penn State Health Milton S. Hershey Medical Center

Please note: Recordings of the concurrent sessions will be available for two weeks following the activity for registered participants only. To receive the maximum credits, 13 hours, you must attend or view all of the sessions listed on the agenda within the two-week time frame. The plenary sessions will not be recorded and must be attended in person.

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 13 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Saturday, April 6, 2024 – 7 AMA PRA Category 1 Credit(s)
• Recorded sessions – 6 AMA PRA Category 1 Credit(s)

Nurse practitioners, please note: This program includes a maximum of 13 hours of pharmacology continuing education as required for certification renewal by the Pennsylvania State Board of Nursing and the American Nurses Credentialing Center (ANCC). All presentations qualify for pharmacology education.

• Saturday, April 6, 2024 – 7 hours of pharmacy continuing education
• Recorded sessions – 6 hours of pharmacy continuing education

Opioid

This program includes a maximum of 1 hour of identification of addiction or the practices of prescribing or dispensing of opioids as required for certification renewal by the Pennsylvania State Board of Nursing and the American Nurses Credentialing Center (ANCC). Please see the agenda for the presentation marked with (opioid).

Nurses using AMA credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing.

These credits meet the criteria set by the ANCC, American Nurses Credentialing Center as contact hours that are acceptable for renewal certification. Additional information is available through the American Nurses Credentialing Center.

• Saturday, April 6, 2024 – 7 hours
• Recorded sessions – 6 hours

The fee is $195 per person and includes the cost of instruction, online handout materials and all listed meals.
Student Discount: $135 per person

To receive the reduced student rates, email verification of student status to ContinuingEd@pennstatehealth.psu.edu

Payment is required at the time of registration. If you have any questions or concerns, please email us at ContinuingEd@pennstatehealth.psu.edu.

Registrations received after Friday, April 5, will incur a $25 late fee.

Cancellations received after Saturday, March 30, will be assessed a $25 processing fee.

No refunds will be made for cancellations received after Tuesday, April 2.

Accommodations are the responsibility of the program participant.

Red Lion Hotel Harrisburg Hershey
4751 Lindle Road, Harrisburg, PA 17111

April 5-6, 2024 – $119 reduced rate per night

Deadline: March 22, 2024

Reservations can be made at 717-939-7841, toll-free at 800-637-4817 or online at Penn State Focus on Pharmacology.

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational activities. Penn State has a process in place to mitigate any relevant financial relationships with commercial companies disclosed by faculty, course directors and planning committee members. Complete disclosure information will be provided to participants at the beginning of the activity.

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D6999